West Branch Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.39M |
| 2 |
Microsoft
MSFT
|
+$819K |
| 3 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$725K |
| 4 |
Johnson & Johnson
JNJ
|
+$690K |
| 5 |
Nike
NKE
|
+$671K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$570K |
| 2 |
Dominion Energy
D
|
+$520K |
| 3 |
Lockheed Martin
LMT
|
+$478K |
| 4 |
CVS Health
CVS
|
+$409K |
| 5 |
Valero Energy
VLO
|
+$407K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.01% |
| 2 | Communication Services | 13.87% |
| 3 | Consumer Discretionary | 12.07% |
| 4 | Healthcare | 11.03% |
| 5 | Financials | 8.61% |
Similar funds
West Branch Capital's Q2 2020 Portfolio in Review
As of Q2 2020, West Branch Capital held 87 positions worth $142M, up 36% from $105M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
West Branch Capital deployed $14.3M of net new capital in Q2 2020, opening 13 new positions and adding to 41 existing holdings. Its largest new stake was Schwab Short-Term US Treasury ETF: 28,068 shares worth $725K.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Amgen, an estimated $570K trimmed.
- West Branch Capital's largest Q2 2020 buy was Schwab Short-Term US Treasury ETF: 28,068 shares worth $725K.
- West Branch Capital added most to Meta Platforms (Facebook) in Q2 2020, an estimated $1.39M increase.
- West Branch Capital's biggest Q2 2020 reduction was Amgen, cutting an estimated $570K.
- West Branch Capital fully exited CVS Health in Q2 2020, selling an estimated $409K.
- West Branch Capital's ten largest holdings make up 48% of its $142M portfolio in Q2 2020.
- West Branch Capital opened 13 new positions and closed 4 in Q2 2020.
- West Branch Capital's portfolio value rose 36% quarter-over-quarter to $142M.
Based on West Branch Capital's 13F filing for Q2 2020, filed 8 Jul 2020.